Y-mAbs Therapeutics Inc.

NASDAQ: YMAB · Real-Time Price · USD
8.51
0.00 (0.00%)
At close: Aug 14, 2025, 3:59 PM
8.51
0.00%
Pre-market: Aug 15, 2025, 04:50 AM EDT

Y-mAbs Therapeutics Revenue

Y-mAbs Therapeutics reported an annual revenue of $87.69M, reflecting a 3.38% growth. For the quarter ending June 30, 2025, Y-mAbs Therapeutics generated $19.52M in revenue.
Revenue (ttm)
87.69M
Revenue Growth
3.38%
Price / Sales Ratio
3.96
Revenue / Employee
843.13K
Employees
104
Market Cap
386.68M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.